Population pharmacokinetics of weekly docetaxel in patients with advanced cancer
Kellie A. Slaviero(The University of Sydney), Laurent P. Rivory(The University of Sydney), Andrew J. McLachlan(The University of Sydney), Stephen Clarke(The University of Sydney), E. Blair(The University of Sydney)
Cited by 69
Related Papers
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
|The Lancet Oncology|2012|526
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467